Healthcare -
Biotechnology - NASDAQ - US
$ 4.07
-2.63 %
$ 141 M
Market Cap
-4.33
P/E
GNLX - CASH & EQUIVALENTS
Cash & Equivalents GNLX - Genelux Corporation
9.42 M
LAST VALUE
44.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR